GlucoModicum
Non-invasive, needle-free glucose monitoring for people with diabetes, based on magnetohydrodynamic technology
Highlights
- New on EvolcAdded 2026-10-28
About GlucoModicum
GlucoModicum develops needle-free glucose monitoring based on its proprietary magnetohydrodynamic (MHD) platform. Its first product is a non-invasive, wearable glucose monitor for patients with diabetes. The company also offers Sofio, a modular, single-day glucose monitoring solution with no needles and no long sensor commitment.
The target users are patients with diabetes.
GlucoModicum was founded in 2018 as a spinout of the University of Helsinki and is headquartered in Helsinki, Finland. Its team combines clinical research, engineering and industrial development, and the company is hiring for open positions.
Product: Sofio, a modular single-day needle-free glucose monitoring solution built on MHD technology; a non-invasive wearable glucose monitor
Jobs at GlucoModicum
More biotech & pharma companies
Glykos Finland
Develops antibody-drug conjugates and glycan analysis services for pharmaceutical companies and research institutionsNew on EvolcGrindeks Kalceks Suomi
Finnish subsidiary that imports and sells prescription, hospital, pharmacy and self-care medicines made at its parent's European plantsYoung companyNew on EvolcHumGel
Human tumor-derived cell matrix (MyoGel) for cancer research labs running invasion and drug-testing assaysYoung companyNew on EvolcKÄÄPÄ BioTech
Standardised functional mushroom extracts for pharmaceutical, nutraceutical and wellness product developersNew on EvolcLignoSphere Company
Colloidal lignin particles from kraft lignin for coating and adhesive manufacturers seeking fossil-free phenolic substitutesYoung companyNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- CookieYes
- Google reCAPTCHA
- PHP
- WordPress
- jQuery
- nginx